92 research outputs found
GATA4-targeted compound exhibits cardioprotective actions against doxorubicin-induced toxicity in vitro and in vivo : establishment of a chronic cardiotoxicity model using human iPSC-derived cardiomyocytes
Doxorubicin is a widely used anticancer drug that causes dose-related cardiotoxicity. The exact mechanisms of doxorubicin toxicity are still unclear, partly because most in vitro studies have evaluated the effects of short-term high-dose doxorubicin treatments. Here, we developed an in vitro model of long-term low-dose administration of doxorubicin utilizing human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). Moreover, given that current strategies for prevention and management of doxorubicin-induced cardiotoxicity fail to prevent cancer patients developing heart failure, we also investigated whether the GATA4-targeted compound 3i-1000 has cardioprotective potential against doxorubicin toxicity both in vitro and in vivo. The final doxorubicin concentration used in the chronic toxicity model in vitro was chosen based on cell viability data evaluation. Exposure to doxorubicin at the concentrations of 1-3 mu M markedly reduced (60%) hiPSC-CM viability already within 48 h, while a 14-day treatment with 100 nM doxorubicin concentration induced only a modest 26% reduction in hiPCS-CM viability. Doxorubicin treatment also decreased DNA content in hiPSC-CMs. Interestingly, the compound 3i-1000 attenuated doxorubicin-induced increase in pro-B-type natriuretic peptide (proBNP) expression and caspase-3/7 activation in hiPSC-CMs. Moreover, treatment with 3i-1000 for 2 weeks (30 mg/kg/day, i.p.) inhibited doxorubicin cardiotoxicity by restoring left ventricular ejection fraction and fractional shortening in chronic in vivo rat model. In conclusion, the results demonstrate that long-term exposure of hiPSC-CMs can be utilized as an in vitro model of delayed doxorubicin-induced toxicity and provide in vitro and in vivo evidence that targeting GATA4 may be an effective strategy to counteract doxorubicin-induced cardiotoxicity.Peer reviewe
Assessment of a Cyclic Bending Test Method for Printed Flexible Supercapacitor
Printed flexible supercapacitor (SC) is seen as an attractive alternative to replace batteries as energy storage unit in energy autonomous sensors. This paper assesses a cyclic bending test method for printed flexible SC. The test is evaluated using four material stacks for printed SC in five different bending radii. The measurement system analysis (MSA) found that the calculated bending radii under all test conditions exhibit variation within a range of 0.3 mm, and the variation takes up less than 8% of bending radius. The measurement system is subjected to 9% total variation, which is within acceptable range. The variation was mainly caused by the uneven thickness distribution across the SC due to its structure. Thus, the variation caused by the test method and measurement is even smaller. In addition, the SC's bending radius subjected to even smaller variation in cyclic bending test. These indicate that this test method is highly reliable and repeatable for evaluating flexible SC.acceptedVersionPeer reviewe
Nuclear Receptor-Like Structure and Interaction of Congenital Heart Disease-Associated Factors GATA4 and NKX2-5
Aims Transcription factor GATA4 is a dosage sensitive regulator of heart development and alterations in its level or activity lead to congenital heart disease (CHD). GATA4 has also been implicated in cardiac regeneration and repair. GATA4 action involves combinatorial interaction with other cofactors such as NKX2-5, another critical cardiac regulator whose mutations also cause CHD. Despite its critical importance to the heart and its evolutionary conservation across species, the structural basis of the GATA4-NKX2-5 interaction remains incompletely understood. Methods and Results A homology model was constructed and used to identify surface amino acids important for the interaction of GATA4 and NKX2-5. These residues were subjected to site-directed mutagenesis, and the mutant proteins were characterized for their ability to bind DNA and to physically and functionally interact with NKX2-5. The studies identify 5 highly conserved amino acids in the second zinc finger (N272, R283, Q274, K299) and its C-terminal extension (R319) that are critical for physical and functional interaction with the third alpha helix of NKX2-5 homeodomain. Integration of the experimental data with computational modeling suggests that the structural arrangement of the zinc finger-homeodomain resembles the architecture of the conserved DNA binding domain of nuclear receptors. Conclusions The results provide novel insight into the structural basis for protein-protein interactions between two important classes of transcription factors. The model proposed will help to elucidate the molecular basis for disease causing mutations in GATA4 and NKX2-5 and may be relevant to other members of the GATA and NK classes of transcription factors.Peer reviewe
Diseño y cálculo de un reductor de velocidad para una cinta transportadora
El projecte de final de grau que s’ha realitzat a continuaciĂł consisteix a dissenyar i calcular un reductor de velocitat per la seva aplicaciĂł a una cinta transportadora de cereal.Primerament, s’han valorat les necessitats prèvies de la cinta com son lasevavelocitat de funcionament, el pes mĂ xim de carrega que arrossega y la potència necessĂ ria per complir tots aquests requeriments. A continuaciĂł, s’ha començat el disseny i cĂ lcul de les diferents parts que conformen el reductor. Començant per la relaciĂł de transmissiĂł, les caracterĂstiques i dimensions dels engranatges cilĂndrics rectes, el lubricant utilitzat, disposiciĂł i mida dels eixos, les unions a torsiĂł i els altres elements necessaris pel funcionament del reductor.En tercer lloc, per a la confecciĂł dels plĂ nols i diferents comprovacions, s’ha simulat amb el programa CAD i CAE de SolidWorks el reductor de velocitat i tots els seus elements.Per Ăşltim, s’ha confeccionat un plec de condicions per aclarir les clĂ usules i execuciĂł del projecte. AixĂ com un pressupost per concloure el cost total i de cada una de les parts del reductor de velocitat
Astrocyte Progenitors Derived From Patients With Alzheimer Disease Do Not Impair Stroke Recovery in Mice
Background: Species-specific differences in astrocytes and their Alzheimer disease-associated pathology may influence cellular responses to other insults. Herein, human glial chimeric mice were generated to evaluate how Alzheimer disease predisposing genetic background in human astrocytes contributes to behavioral outcome and brain pathology after cortical photothrombotic ischemia. Methods: Neonatal (P0) immunodeficient mice of both sexes were transplanted with induced pluripotent stem cell-derived astrocyte progenitors from Alzheimer disease patients carrying PSEN1 exon 9 deletion (PSEN1 Delta E9), with isogenic controls, with cells from a healthy donor, or with mouse astrocytes or vehicle. After 14 months, a photothrombotic lesion was produced with Rose Bengal in the motor cortex. Behavior was assessed before ischemia and 1 and 4 weeks after the induction of stroke, followed by tissue perfusion for histology. Results: Open field, cylinder, and grid-walking tests showed a persistent locomotor and sensorimotor impairment after ischemia and female mice had larger infarct sizes; yet, these were not affected by astrocytes with PSEN1 Delta E9 background. Staining for human nuclear antigen confirmed that human cells successfully engrafted throughout the mouse brain. However, only a small number of human cells were positive for astrocytic marker GFAP (glial fibrillary acidic protein), mostly located in the corpus callosum and retaining complex human-specific morphology with longer processes compared with host counterparts. While host astrocytes formed the glial scar, human astrocytes were scattered in small numbers close to the lesion boundary. A beta (beta-amyloid) deposits were not present in PSEN1 Delta E9 astrocyte-transplanted mice. Conclusions: Transplanted human cells survived and distributed widely in the host brain but had no impact on severity of ischemic damage after cortical photothrombosis in chimeric mice. Only a small number of transplanted human astrocytes acquired GFAP-positive glial phenotype or migrated toward the ischemic lesion forming glial scar. PSEN1 Delta E9 astrocytes did not impair behavioral recovery after experimental stroke.Peer reviewe
Discovery of Small Molecules Targeting the Synergy of Cardiac Transcription Factors GATA4 and NKX2-5
Transcription factors are pivotal regulators of gene transcription, and many diseases are associated with the deregulation of transcriptional networks. In the heart, the transcription factors GATA4 and NKX2-5 are required for cardiogenesis. GATA4 and NKX2-5 interact physically, and the activation of GATA4, in cooperation with NKX2-5, is essential for stretch-induced cardiomyocyte hypertrophy. Here, we report the identification of four small molecule families that either inhibit or enhance the GATA4-NKX2-5 transcriptional synergy. A fragment-based screening, reporter gene assay, and pharmacophore search were utilized for the small molecule screening, identification, and optimization. The compounds modulated the hypertrophic agonist-induced cardiac gene expression. The most potent hit compound, N-[4-(diethylamino)phenyl]-5-methyl-3-phenylisoxazole-4-carboxamide (3, IC50 = 3 mu M), exhibited no activity on the protein kinases involved in the regulation of GATA4 phosphorylation. The identified and chemically and biologically characterized active compound, and its derivatives may provide a novel class of small molecules for modulating heart regeneration.Peer reviewe
Cardiac Actions of a Small Molecule Inhibitor Targeting GATA4–NKX2-5 Interaction
Transcription factors are fundamental regulators of gene transcription, and many diseases, such as heart diseases, are associated with deregulation of transcriptional networks. In the adult heart, zinc-finger transcription factor GATA4 is a critical regulator of cardiac repair and remodelling. Previous studies also suggest that NKX2-5 plays function role as a cofactor of GATA4. We have recently reported the identification of small molecules that either inhibit or enhance the GATA4–NKX2-5 transcriptional synergy. Here, we examined the cardiac actions of a potent inhibitor (3i-1000) of GATA4–NKX2-5 interaction in experimental models of myocardial ischemic injury and pressure overload. In mice after myocardial infarction, 3i-1000 significantly improved left ventricular ejection fraction and fractional shortening, and attenuated myocardial structural changes. The compound also improved cardiac function in an experimental model of angiotensin II -mediated hypertension in rats. Furthermore, the up-regulation of cardiac gene expression induced by myocardial infarction and ischemia reduced with treatment of 3i-1000 or when micro- and nanoparticles loaded with 3i-1000 were injected intramyocardially or intravenously, respectively. The compound inhibited stretch- and phenylephrine-induced hypertrophic response in neonatal rat cardiomyocytes. These results indicate significant potential for small molecules targeting GATA4–NKX2-5 interaction to promote myocardial repair after myocardial infarction and other cardiac injuries.Peer reviewe
Luminescent Downshifting by Photo-Induced Sol-Gel Hybrid Coatings: Accessing Multifunctionality on Flexible Organic Photovoltaics via Ambient Temperature Material Processing
A novel high-durability multifunctional organic-inorganic hybrid coating material is presented in this work as luminescent down-shifting (LDS) host matrix system for flexible organic photovoltaic (OPV) devices. Such new LDS coating is obtained by incorporating a convenient fluorescent organic dye in an appropriately functionalized fluoropolymeric resin that can be readily crosslinked by means of a dual-cure mechanism with a single-step ambient-temperature photo-induced sol-gel process. Due to its peculiar characteristics, the newly proposed system may be readily implemented in heat-sensitive flexible devices. By carefully tuning the amount of organic fluorophore in the hybrid coating material, a maximum increase in power conversion efficiency exceeding 4% is achieved on devices incorporating the new LDS layer with respect to control systems. This represents the highest efficiency enhancement reported to date on flexible OPVs by means of a polymer-based LDS layer. In addition, long-term accelerated weathering tests (>550 h) highlight the excellent stability of LDS-coated OPV devices, which can retain 80% of their initial performance, as opposed to the dramatic efficiency decay experienced by control uncoated devices. The approach presented here opens the way to the straightforward incorporation of versatile multifunctional light-managing layers on flexible OPV systems for improved device efficiency and lifetime
Cardiac Actions of a Small Molecule Inhibitor Targeting GATA4-NKX2-5 Interaction
Transcription factors are fundamental regulators of gene transcription, and many diseases, such as heart diseases, are associated with deregulation of transcriptional networks. In the adult heart, zinc-finger transcription factor GATA4 is a critical regulator of cardiac repair and remodelling. Previous studies also suggest that NKX2-5 plays function role as a cofactor of GATA4. We have recently reported the identification of small molecules that either inhibit or enhance the GATA4-NKX2-5 transcriptional synergy. Here, we examined the cardiac actions of a potent inhibitor (3i-1000) of GATA4-NKX2-5 interaction in experimental models of myocardial ischemic injury and pressure overload. In mice after myocardial infarction, 3i-1000 significantly improved left ventricular ejection fraction and fractional shortening, and attenuated myocardial structural changes. The compound also improved cardiac function in an experimental model of angiotensin II-mediated hypertension in rats. Furthermore, the up-regulation of cardiac gene expression induced by myocardial infarction and ischemia reduced with treatment of 3i-1000 or when micro-and nanoparticles loaded with 3i-1000 were injected intramyocardially or intravenously, respectively. The compound inhibited stretch- and phenylephrine-induced hypertrophic response in neonatal rat cardiomyocytes. These results indicate significant potential for small molecules targeting GATA4-NKX2-5 interaction to promote myocardial repair after myocardial infarction and other cardiac injuries
Aus der Welt der Märchen - Unter besonderer Berücksichtigung der Tätigkeit von Lisa Tetzner als Märchenerzählerin
- …